搜索筛选:
搜索耗时0.6629秒,为你在为你在102,267,441篇论文里面共找到 11 篇相符的论文内容
发布年度:
[会议论文] 作者：Xiaoyan Ke,
来源：中华医学会第十一次全国精神医学学术会议暨第三届亚洲神经精神药理学术会议 年份：2013
...
[会议论文] 作者：Wei Zhang,Jing Wang,Xiaoyan Ke,
来源：第十五届全国实验血液学学术会议 年份：2015
...
[期刊论文] 作者：Xueli Tian,Yanfang Wang,Dieyan Chen,Xiaoyan Ke,Wanyun Ma,,
来源：Chinese Journal of Cancer 年份：2017
Dear editor Leukemia ranks as one of the ten most fatal cancers [1].The mortality and incidence of this disease are associated with multiple factors, including...
Clinical characteristic and prognostic factors in Primary Systemic anaplastic large cell lymphoma:re
[会议论文] 作者：Yanfang Wang,Yanli Yang,Jing Wang,Jing Li,Xiaofeng Yang,Xiaoyan Ke,
来源：第四届中国医师协会血液科医师论坛 年份：2010
Primary systemic anaplastic large cell lymphoma (S-ALCL) is a rarely diagnosed disease with highly heterogeneity and variable outcome.Although people have been identified Anaplastic lymphoma kinase (A...
CLINICAL CHARACTERISTICS AND PROGNOSTIC ANALYSIS OF CHINESE PATIENTS WITH DIFFUSE LARGE B-CELL LYMPH
[会议论文] 作者：Xiaoyan Ke,Jing Wang,Zifen Gao,Lingzhi Zhao,Min Li,Hongmei Jing,Jijun Wang,Wei Zhao,Xiao-Feng Yang,
来源：第四届中国医师协会血液科医师论坛 年份：2010
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma in adults.As it is a highly heterogenous disease, many studies have focused on finding useful prognostic factors to help guide...
A Fiber Tractography Study of Social-Emotional Related Fiber Tracts in Children and Adolescents with
[期刊论文] 作者：Li,Hui Fang,Wenming Zheng,Lu Qian,Yunhua Xiao,Qiaorong Wu,Chen Chang,Chaoyong Xiao,Kangkang Chu,Xiaoyan Ke,
来源：神经科学通报（英文版） 年份：2017
The symptoms of autism spectrum disorder (ASD) have been hypothesized to be caused by changes in brain connectivity.From the clinical perspective,the “disconnectivity” hypothesis has been used to explain characteristic impairments in “so......
Phase 1 studies comparing safety, tolerability, pharmacokinetics and pharmacodynamics of HLX01(a rit
[期刊论文] 作者：Yuankai Shi,Qingyuan Zhang,Xiaohong Han,Yan Qin,Xiaoyan Ke,Hang Su,Li Liu,Jinxiang Fu,Jie Jin,Jifeng,
来源：中国癌症研究:英文版 年份：2021
Objective: This study aimed to compare the pharmacokinetic, pharmacodynamic and safety profiles of HLX01(a rituximab biosimilar) and reference rituximab sourced from China(Mab Thera?;rituximab-CN).Methods: Here we report the results of two ......
[会议论文] 作者：Shenmiao Yang,Jianyong Li,Lugui Qiu,Daobin Zhou,Junmin Li,Xiaoyan Ke,Yu Hu,Peng Wu,Na Li,Jingzhao Wang,
来源：The 35th World Congress of the International Society of Hema 年份：2014
...
[会议论文] 作者：Shenmiao Yang,Jianyong Li,Lugui Qiu,Daobin Zhou,Junmin Li,Xiaoyan Ke,Yu Hu,Peng Wu,Na Li,Angela Howes,
来源：The 35th World Congress of the International Society of Hema 年份：2014
Background CLL is one of the most common forms of leukemia among adults.Despite advances in the treatment of CLL,including chemotherapy,chemoimmunotherapy (CIT),and stem cell transplant (SCT),the dise...
Phase 1 studies comparing safety,tolerability,pharmacokinetics and pharmacodynamics of HLX01(a ritux
[期刊论文] 作者：Yuankai Shi,Qingyuan Zhang,Xiaohong Han,Yan Qin,Xiaoyan Ke,Hang Su,Li Liu,Jinxiang Fu,Jie Jin,Jifeng,
来源：中国癌症研究（英文版） 年份：2004
Objective:This study aimed to compare the pharmacokinetic,pharmacodynamic and safety profiles of HLX01(a rituximab biosimilar)and reference rituximab sourced fr...
PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic ly
[期刊论文] 作者：Wen Zheng,Hanyun Ren,Xiaoyan Ke,Mei Xue,Yongqing Zhang,Yan Xie,Ningjing Lin,Meifeng Tu,Weiping Liu,Lingyan,
来源：Chinese Journal of Cancer Research 年份：2017
Objective: Although L-asparaginase(L-ASP) is a standard treatment for lymphoblastic lymphoma(LBL),hypersensitivity reactions by some patients limit its applicat...
相关搜索：
